HemoShear Raises $4M for Cell-Based Surrogate Systems
October 26, 2012
Share:
HemoShear, a biotech research company that focuses on developing human and animal cell-based surrogate systems for discovery and assessment of new drug compounds, has completed a $4 million round of VC funding. In total, the Charlottesville, Virg.-based company has raised over $9 million from private or venture investors, with additional funding from government grants
